Leadership

Is Your EHR Transition a Strategic Asset or a Costly Trap?
Organizational Governance Is Your EHR Transition a Strategic Asset or a Costly Trap?

The decision to migrate to a new Electronic Health Record system often represents the single largest capital expenditure a healthcare organization will make in a decade, yet the return on investment remains notoriously difficult to quantify. When a hospital system pivots to a new vendor, it is not

Healthcare Leaders Urge CMS to Delay Medicaid Work Rules
Care Healthcare Leaders Urge CMS to Delay Medicaid Work Rules

The sudden tightening of federal eligibility standards for millions of low-income Americans threatens to destabilize the very foundation of the national healthcare safety net if implemented prematurely. A recent interim final rule issued by the Centers for Medicare & Medicaid Services mandates

Why Do Healthcare Organizations Fail at EHR Transitions?
Organizational Governance Why Do Healthcare Organizations Fail at EHR Transitions?

A physician spending more time staring at a glowing screen than into a patient’s eyes represents the modern clinical tragedy of the digital age. Physicians rank Electronic Health Record (EHR) systems with a median System Usability Scale score of just 45.9 out of 100, effectively placing these m

How is AI Shifting Healthcare from Reactive to Predictive?
Care How is AI Shifting Healthcare from Reactive to Predictive?

The healthcare landscape is currently undergoing a fundamental transformation, moving from a reactive model toward a proactive, predictive ecosystem that prioritizes early detection and systematic prevention over traditional late-stage interventions. This shift is driven by the powerful convergence

How Can Hospitals Beat AI-Driven Payer Denial Tactics?
Organizational Governance How Can Hospitals Beat AI-Driven Payer Denial Tactics?

The administrative back-and-forth between healthcare providers and insurance companies was a predictable, if frustrating, game of manual audits and paper-based appeals for many decades. However, the landscape has shifted dramatically as payers now deploy sophisticated algorithmic tools designed to

Trend Analysis: AI in Drug Discovery Challenges
Organizational Governance Trend Analysis: AI in Drug Discovery Challenges

The biopharmaceutical industry currently stands at a precarious crossroads where the massive infusion of capital into artificial intelligence meets the stubborn, unpredictable reality of human biology. This sector is witnessing a historic influx of capital, with billions of dollars being funneled

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later